economy
April 8, 2026
London's CapVest Officially New Owner of Hemofarm: Acquisition of Majority Stake in German STADA Group Completed
Investment firm CapVest Partners LLP from London announced on the last day of March that it has completed the acquisition of a majority stake in STADA Arzneimittel AG, a German pharmaceutical company specializing in consumer healthcare products, generics, and specialty medicines.
TL;DR
- CapVest Partners LLP, an investment firm from London, has acquired a majority stake in STADA Arzneimittel AG.
- This acquisition signifies a new ownership for Hemofarm, a pharmaceutical company part of the STADA Group.
- The acquisition process began with a binding agreement in September 2025, followed by regulatory approvals.
- STADA achieved strong results in 2025, with revenues of 4.3 billion euros and a record adjusted EBITDA of 961 million euros.
- The transaction is expected to drive STADA's global growth, organic development, and new acquisitions.